Ultra-high revenue growth through 2028

Conviction: 62% · Horizon: 3Y · 2026-07-10
A narrow set of public names can compound sales above 120% annually while still trading at modest NTM revenue multiples

Consensus models that imply more than 120% compound annual revenue growth through 2028 are rare and often unreliable; among names that pass a legitimacy filter, next-twelve-month sales multiples range from about 4x to 16x, with one pre-revenue entrant offering pure growth optionality. Investors who accept execution and dilution risk may find asymmetric upside where revenue ramps faster than the multiple expands.

Instrument Side Target Reason
ONDS Long Forecast revenue trajectory above 120% CAGR through 2028 pairs with a relatively low 4.3x NTM sales multiple, leaving room for re-rating if deliveries match the ramp.
AAOI Long Optical connectivity demand and capacity additions can support a 7.0x NTM sales valuation if hyper-growth materializes and margins scale with volume.
IREN Long Power-and-compute infrastructure exposed to AI workload growth trades at 8.4x NTM sales while models embed very fast top-line compounding through 2028.
NBIS Long A 10.4x NTM sales multiple still embeds aggressive growth; sustained GPU-cloud and platform adoption could justify premium if revenue outpaces capex intensity.
USAR Long Domestic critical-minerals and rare-earth supply chains carry policy tailwinds; 16.2x NTM sales prices a steep ramp that rewards early commercial wins.
AUR Long Pre-revenue status removes near-term multiple anchoring; autonomous-mobility optionality aligns with the same 120%+ growth cohort if commercial deployment begins before 2028.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.